SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066865
Filing Date
2023-08-14
Accepted
2023-08-14 14:30:43
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_bioessence.htm   iXBRL 10-Q 575966
2 CERTIFICATION f10q0623ex31-1_bioessence.htm EX-31.1 8433
3 CERTIFICATION f10q0623ex31-2_bioessence.htm EX-31.2 8104
4 CERTIFICATION f10q0623ex32-1_bioessence.htm EX-32.1 4889
5 CERTIFICATION f10q0623ex32-2_bioessence.htm EX-32.2 5422
6 GRAPHIC image_001.jpg GRAPHIC 7168
  Complete submission text file 0001213900-23-066865.txt   4206510

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cik00001723059-20230630.xsd EX-101.SCH 67332
8 XBRL CALCULATION FILE cik00001723059-20230630_cal.xml EX-101.CAL 37302
9 XBRL DEFINITION FILE cik00001723059-20230630_def.xml EX-101.DEF 228154
10 XBRL LABEL FILE cik00001723059-20230630_lab.xml EX-101.LAB 465114
11 XBRL PRESENTATION FILE cik00001723059-20230630_pre.xml EX-101.PRE 235773
68 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_bioessence_htm.xml XML 420478
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 231168691
SIC: 2834 Pharmaceutical Preparations